Our Mission
To develop next-generation therapeutics that prevent, repair, and transform the treatment of chronic metabolic diseases through a unified, multi-targeted approach, all the while making them affordable and accessible.
Our Values
We’re building a future where better health is proactive, regenerative, and within reach. By scaling accessible, small molecule therapeutics across borders, we aim to shift the standard of care for degenerative conditions from reactive treatment to real biological repair.
Our science is powered by a larger belief: Better health belongs to all.
Tackling metabolic
dysfunction upstream
Driving affordability
and reach
Restoring health through
regeneration
Prioritizing oral GLP-1
for adherence
Solving multiple
conditions together
Tackling metabolic dysfunction upstream
Driving affordability and reach
Restoring health through regeneration
Prioritizing oral GLP-1 for adherence
Solving multiple conditions together
Our science is powered by a larger belief: Better health belongs to all.
Tackling metabolic dysfunction upstream
Driving affordability and reach
Restoring health through regeneration
Prioritizing oral GLP-1 for adherence
Solving multiple conditions together
Current partners & investors
Hummsa is growing, in ideas, in partnerships, and in purpose. We’re here to redefine what’s possible in chronic disease care, not by taking incremental steps, but by engineering bold, integrated solutions from the molecular level up.
Join us as we build what comes next.
